Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET
Company Participants
Susan Morrison - EVP and Chief Administrative Officer.
John Sheridan - President and CEO
Leigh Vosseller - EVP and CFO
Conference Call Participants
Mathew Blackman - Stifel
Steve Lichtman - Oppenheimer & Company
Brooks O'Neil - Lake Street Capital Markets
Matt Miksic - Barclays
Larry Biegelsen - Wells Fargo
Matthew O'Brien - Piper Sandler
Patrick Wood - Morgan Stanley
Matt Taylor - Jefferies
David Roman - Goldman Sachs
Chris Pasquale - Nephron Research
Joshua Jennings - TD Cowen
Shagun Singh - RBC
William Plovanic - Canaccord Genuity
Joanne Wuensch - Citi
Issie Kirby - Redburn Atlantic
Danielle Antalffy - UBS
Mike Kratky - Leerink Partners
Jeff Johnson - Baird
Jayson Bedford - Raymond James
Michael Polark - Wolfe Research
Travis Steed - Bank of America
Operator
Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions].
I would now like to hand the conference over to your speaker today, Susan Morrison, Executive Vice President and Chief Administrative Officer.
Susan Morrison
Hello, everyone, and thanks for joining Tandem's Third Quarter 2024 Earnings Call.
Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, our product pipeline, development timelines, and financial performance and operating plans, and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.
A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the risk factors portion and elsewhere in our most recent annual report on Form 10-K, as updated by our most recent quarterly report on Form 10-Q. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or other factors.
Today's discussion will also include references to a number of GAAP and non-GAAP financial measures. Non-GAAP financial measures are provided to give our investors information that we believe is indicative of our core operating performance and reflects our ongoing business operations. We believe these non-GAAP financial measures facilitate better comparisons of operating results across reporting periods.